|
PPM1L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.678320E-02 |
| Normal-vs-Stage3 |
9.99200722162641E-16 |
| Normal-vs-Stage4 |
1.62470037423645E-12 |
| Stage1-vs-Stage2 |
1.090370E-02 |
| Stage1-vs-Stage3 |
3.443600E-01 |
| Stage1-vs-Stage4 |
4.764500E-03 |
| Stage2-vs-Stage3 |
4.501600E-03 |
| Stage2-vs-Stage4 |
5.010800E-04 |
| Stage3-vs-Stage4 |
1.553770E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
4.72939465367972E-11 |
| Normal-vs-Asian |
3.49530404619713E-11 |
| Caucasian-vs-AfricanAmerican |
8.849400E-01 |
| Caucasian-vs-Asian |
5.753200E-01 |
| AfricanAmerican-vs-Asian |
7.450400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.37587727269783E-14 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
4.417800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.28626015289046E-14 |
| Normal-vs-Age(41-60Yrs) |
1.92523774700248E-12 |
| Normal-vs-Age(61-80Yrs) |
2.05009997866767E-09 |
| Normal-vs-Age(81-100Yrs) |
2.042800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.948600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.123820E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.550800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.848400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.102400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.833200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.06739997238503E-09 |
| Classical-VS-Follicular |
1.20230000000277E-06 |
| Classical-VS-Other |
2.023800E-04 |
| Classical-VS-Normal |
1.64568358940187E-12 |
| Tall-VS-Follicular |
6.60089760629035E-11 |
| Tall-VS-Other |
7.135600E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
2.19489981745369E-10 |
| Follicular-VS-Normal |
8.757400E-03 |
| Other-VS-Normal |
<1E-12 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.03129998669283E-10 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
2.93619999980343E-07 |
|
|
